Delivery Order SPE2DR25D3501-SPE2DR26FL8TU
Award Date 11/17/25
Potential Completion Date 12/9/25
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Hemlibra 105 mg/0.7 mL vials, a specialty pharmaceutical product used in hemophilia treatment. This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,168.26 and is scheduled for completion by November 10, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $24,673.08 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Hemlibra 105 mg/0.7 ml vials. This is a firm fixed-price delivery order with a completion date of September 2, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded. Hemlibra is a specialty pharmaceutical product used in the treatment of hemophilia,...
- The Defense Logistics Agency awarded a delivery order valued at $26,451.57 to AmerisourceBergen Drug Corp for the supply of HEMLIBRA 150 mg/ml vials. This firm fixed price contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its...
- This is a $24,673.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hemlibra 105 mg/0.7 ml vials, a specialty medication. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of HEMLIBRA 105 mg/0.7 mL vials totaling $12,336.54, with completion scheduled for November 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,673.08 to AmerisourceBergen Drug Corp for the supply of HEMLIBRA 105 mg/0.7 ml vials. This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and was awarded on July 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,564.08 firm fixed-price delivery order is for the supply of HEMLIBRA 150 MG/ML VIALML, a critical medical product, with a period of performance through January 22, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $23,330.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,565,282 units of the specialty pharmaceutical product Hemlibra (105 mg/0.7 ml vial). The contract has an ultimate completion date of August 19, 2024 and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,336.54 firm fixed-price delivery order contract is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $16,442.54 to supply HEMLIBRA 150 MG/ML VIALML by December 13, 2023. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product from its headquarters in Conshohocken, Pennsylvania to the agency. No set-aside designation was applied to this award issued against an existing indefinite delivery contract held by Amerisourcebergen with the...